Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
From Benzinga
 
   Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
   
  March 16, 2022
  Tickers 
   PRTA
  
  
  From Benzinga
 
   Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
   
  March 15, 2022
  Tickers 
   GANX
  
  
  From Benzinga
 
   Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
   
  
  
  March 15, 2022
  From Benzinga
 
   AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
   
  
  
  February 15, 2022
  From Benzinga
 
   Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
   
  January 26, 2022
  Tickers 
   CRTX
  
  
  From Benzinga
 
   FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
   
  January 13, 2022
  Tickers 
   DNLI
  
  
  From Benzinga
 From Benzinga
 
   Why Biogen's Alzheimer's drug Aduhelm is so controversial
   
  
  January 04, 2022
  From CNBC.com News
 
   Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
   
  December 21, 2021
  Tickers 
   ACAD
  
  
  From Benzinga
 
   After Much Criticism, Biogen Slashes Aduhelm Price In Half
   
  December 20, 2021
  Tickers 
   BIIB
  
  
  From Benzinga
 
   Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
   
  December 17, 2021
  Tickers 
   ALZN
  
  
  From Benzinga
 
   EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
   
  December 17, 2021
  Tickers 
   BIIB
  
  
  From Benzinga
 From Benzinga
 
   Thanksgiving Left-Overs 2021
   
  
  November 30, 2021
  From Stock Gumshoe
 
   Waiting to talk finance with an aging parent in cognitive decline is a mistake, experts say
   
  
  November 30, 2021
  From CNBC.com News
 
   European Regulator Votes Down Biogen's Alzheimer's Drug
   
  November 17, 2021
  Tickers 
   BIIB
  
  
  From Benzinga
 
   Why Are Biogen Shares Gaining Today?
   
  
  
  November 12, 2021
  From Benzinga
 
   Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
   
  
  
  November 11, 2021
  From Benzinga
 
   Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
   
  
  
  November 10, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.